Literature DB >> 18483344

Body mass index, physical activity, and bladder cancer in a large prospective study.

Corinna Koebnick1, Dominique Michaud, Steven C Moore, Yikyung Park, Albert Hollenbeck, Rachel Ballard-Barbash, Arthur Schatzkin, Michael F Leitzmann.   

Abstract

Increased body size and lack of physical activity are associated with increased risk of several cancers, but the relations of body mass index (BMI) and physical activity to bladder cancer are poorly understood. We investigated the associations between BMI, physical activity, and bladder cancer in the NIH-AARP Diet and Health Study, a prospective cohort of 471,760 U.S. men and women, followed from 1995 to 2003. During 3,404,642 person-years of follow-up, we documented 1,719 incident cases of bladder cancer. Compared with normal weight, obesity was associated with an up to 28% increased risk for bladder cancer. The multivariate relative risks of bladder cancer for BMI values of 18.5 to 24.9 (reference), 25.0 to 29.9, 30.0 to 34.9, and >or=35 kg/m2 were 1.0, 1.15, 1.22, and 1.28 (95% confidence interval, 1.02-1.61; P trend = 0.028). The association between BMI and bladder cancer was consistent among subgroups defined by gender, education, smoking status, and other potential effect modifiers. In contrast, physical activity showed no statistically significant relation with bladder cancer. After multivariate adjustment, including BMI, the relative risks of bladder cancer for increasing frequency of physical activity [0 (reference), <1, 1-2, 3-4, and >or=5 times a week] were 1.0, 0.85, 0.89, 0.91, and 0.87 (95% confidence interval, 0.74-1.02; P trend = 0.358), respectively. In conclusion, these findings provide support for a modest adverse effect of adiposity on risk for bladder cancer. In contrast, our results do not suggest a relation between physical activity and bladder cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18483344     DOI: 10.1158/1055-9965.EPI-08-0026

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  44 in total

1.  [Prevention of uro-oncological diseases].

Authors:  B J Schmitz-Dräger; G Lümmen; E Bismarck; C Fischer
Journal:  Urologe A       Date:  2012-05       Impact factor: 0.639

2.  Diabetes and risk of bladder cancer: evidence from a case-control study in New England.

Authors:  Todd MacKenzie; Michael S Zens; Assiamira Ferrara; Alan Schned; Margaret R Karagas
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

3.  Association of body mass index with bladder cancer risk in men depends on abdominal obesity.

Authors:  Jin Bong Choi; Jung Ho Kim; Sung-Hoo Hong; Kyung-Do Han; U-Syn Ha
Journal:  World J Urol       Date:  2019-02-26       Impact factor: 4.226

Review 4.  Lifestyle and nutritional modifiable factors in the prevention and treatment of bladder cancer.

Authors:  Marilyn L Kwan; Brandon Garren; Matthew E Nielsen; Li Tang
Journal:  Urol Oncol       Date:  2018-04-25       Impact factor: 3.498

5.  Body mass and smoking are modifiable risk factors for recurrent bladder cancer.

Authors:  Asaf Wyszynski; Sam A Tanyos; Judy R Rees; Carmen J Marsit; Karl T Kelsey; Alan R Schned; Eben M Pendleton; Maria O Celaya; Michael S Zens; Margaret R Karagas; Angeline S Andrew
Journal:  Cancer       Date:  2013-10-10       Impact factor: 6.860

6.  Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer.

Authors:  Tianyuan Xu; Zhaowei Zhu; Xianjin Wang; Leilei Xia; Xiaohua Zhang; Shan Zhong; Fukang Sun; Yu Zhu; Zhoujun Shen
Journal:  Int Urol Nephrol       Date:  2015-05-26       Impact factor: 2.370

7.  The cost of obesity and overweight in 2005: a case study of Alberta, Canada.

Authors:  Ellen Moffatt; Lorraine G Shack; Graham J Petz; Janis K Sauvé; Karen Hayward; Ron Colman
Journal:  Can J Public Health       Date:  2011 Mar-Apr

8.  Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology.

Authors:  A Goday; I Barneto; J M García-Almeida; A Blasco; A Lecube; C Grávalos; P Martínez de Icaya; R de las Peñas; S Monereo; L Vázquez; J E Palacio; P Pérez-Segura
Journal:  Clin Transl Oncol       Date:  2015-06-03       Impact factor: 3.405

9.  Obesity adversely impacts disease specific outcomes in patients with upper tract urothelial carcinoma.

Authors:  Behfar Ehdaie; Thomas F Chromecki; Richard K Lee; Yair Lotan; Vitaly Margulis; Pierre I Karakiewicz; Giacomo Novara; Jay D Raman; Casey Ng; William T Lowrance; Douglas S Scherr; Shahrokh F Shariat
Journal:  J Urol       Date:  2011-05-14       Impact factor: 7.450

10.  Body mass index and cancer incidence: the FINRISK study.

Authors:  Xin Song; Eero Pukkala; Tadeusz Dyba; Jaakko Tuomilehto; Vladislav Moltchanov; Satu Männistö; Pekka Jousilahti; Qing Qiao
Journal:  Eur J Epidemiol       Date:  2014-07-06       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.